Chondroitin Sulfate

Category
metabolite
Routes
Oral (PO)
Half-Life (t½)
PO: 15h
Formula
C13H21NO15S
Molecular Weight
463.37 g/mol
PubChem CID
24766
Aliases
Chondroitin 4-sulfate, CS

Pharmacological Mechanism

Sulfated GAG of alternating glucuronic acid + N-acetylgalactosamine. Major cartilage matrix component. Oral CS → small fragments absorbed (~10% F) → proposed to accumulate in synovium + inhibit IL-1β-driven MMP + aggrecanase activity. Modest symptomatic OA benefit in meta-analyses; structural disease modification debatable. EU Rx in some countries.

Half-Life & Elimination Curve (PO: 15h)

100%50%25%12.5%0%0h0×t½15h1×t½30h2×t½45h3×t½60h4×t½3.1d5×t½0×t½ (0h): 100% remaining1×t½ (15h): 50% remaining2×t½ (30h): 25% remaining3×t½ (45h): 12.5% remaining4×t½ (60h): 6.3% remaining5×t½ (3.1d): 3.1% remaining
Plasma (PO)t½ Decay (15h)
  • 0×t½0h100%
  • 1×t½15h50%
  • 2×t½30h25%
  • 3×t½45h12.5%
  • 4×t½60h6.3%
  • 5×t½3.1d3.1%
Elimination t½15h (PO)
Rate Constant (ke)0.0462 h⁻¹
Time to Peak (Tmax)2h
97% Washout (5×t½)3.1d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References